Company: TXG
Filing Date: 2025-06-05
Form Type: 8-K
Source: 0001770787-25-000040
Chunk: 0

Company: 10x Genomics, Inc.
Filing Date: 2025-06-05
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders

The annual meeting of stockholders of 10x Genomics, Inc. (the "Company") was held on June 3, 2025 via live webcast (the “ Annual Meeting”). At the Annual Meeting, there were present, virtually or by proxy, holders of 108,937,350 shares of the Company's Class A and Class B common stock, representing 216,567,558, or approximately 87.7%, of the 246,945,247 eligible votes, constituting a quorum. The matters submitted to a vote at the Annual Meeting and the final voting results of such matters were as follows:

Proposal 1 - Election of Directors

The Company’s stockholders approved the election of two Class III directors, each to hold office for a three-year term expiring at the Company’s 2028 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified or until his or her earlier resignation or removal. The final voting results were as follows:

  Nominee                 Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ───────────────────────────────────────────────────────────────────────────────────────────────
  Sri Kosaraju          189,313,724          7,243,542          172,526            19,837,766  
  Shehnaaz Suliman      168,973,468         27,595,026          161,298            19,837,766  

Proposal 2 - Ratification of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2025. There were no broker non-votes on this proposal. The final voting results were as follows:

    Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────────────────
  215,766,816            312,396          488,346      —                 

Proposal 3 - Non-binding, Advisory Vote to Approve Executive Compensation of Named Executive Officers

The Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as described in more detail in the Company's definitive proxy statement filed with the U. S. Securities and Exchange Commission on April 14,